These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
209 related items for PubMed ID: 8614514
1. Valproic acid hepatic fatalities. III. U.S. experience since 1986. Bryant AE, Dreifuss FE. Neurology; 1996 Feb; 46(2):465-9. PubMed ID: 8614514 [Abstract] [Full Text] [Related]
2. Effects of age and polytherapy, risk factors of valproic acid (VPA) hepatotoxicity, on the excretion of thiol conjugates of (E)-2,4-diene VPA in people with epilepsy taking VPA. Gopaul S, Farrell K, Abbott F. Epilepsia; 2003 Mar; 44(3):322-8. PubMed ID: 12614387 [Abstract] [Full Text] [Related]
3. Valproic acid hepatic fatalities: a retrospective review. Dreifuss FE, Santilli N, Langer DH, Sweeney KP, Moline KA, Menander KB. Neurology; 1987 Mar; 37(3):379-85. PubMed ID: 3102998 [Abstract] [Full Text] [Related]
4. Valproic acid-induced hepatopathy: nine new fatalities in Germany from 1994 to 2003. Koenig SA, Buesing D, Longin E, Oehring R, Häussermann P, Kluger G, Lindmayer F, Hanusch R, Degen I, Kuhn H, Samii K, Jungck A, Brückner R, Seitz R, Boxtermann W, Weber Y, Knapp R, Richard HH, Weidner B, Kasper JM, Haensch CA, Fitzek S, Hartmann M, Borusiak P, Müller-Deile A, Degenhardt V, Korenke GC, Hoppen T, Specht U, Gerstner T. Epilepsia; 2006 Dec; 47(12):2027-31. PubMed ID: 17201699 [Abstract] [Full Text] [Related]
5. Severe hepatotoxicity during valproate therapy: an update and report of eight new fatalities. König SA, Siemes H, Bläker F, Boenigk E, Gross-Selbeck G, Hanefeld F, Haas N, Köhler B, Koelfen W, Korinthenberg R. Epilepsia; 1994 Dec; 35(5):1005-15. PubMed ID: 7925143 [Abstract] [Full Text] [Related]
6. Children versus adults: pharmacokinetic and adverse-effect differences. Anderson GD. Epilepsia; 2002 Dec; 43 Suppl 3():53-9. PubMed ID: 12060006 [Abstract] [Full Text] [Related]
7. Non-fatal and fatal liver failure associated with valproic acid. Schmid MM, Freudenmann RW, Keller F, Connemann BJ, Hiemke C, Gahr M, Kratzer W, Fuchs M, Schönfeldt-Lecuona C. Pharmacopsychiatry; 2013 Mar; 46(2):63-8. PubMed ID: 22915484 [Abstract] [Full Text] [Related]
8. [Acute hepatic failure associated with valproic acid in children. Report of 3 cases]. Antoniuk SA, Bruck I, Hönnicke LR, Martins LT, Carreiro JE, Cat R. Arq Neuropsiquiatr; 1996 Dec; 54(4):652-4. PubMed ID: 9201347 [Abstract] [Full Text] [Related]
9. Valproic acid and fatalities in children: a review of individual case safety reports in VigiBase. Star K, Edwards IR, Choonara I. PLoS One; 2014 Dec; 9(10):e108970. PubMed ID: 25302991 [Abstract] [Full Text] [Related]
10. Fatal liver failure in 16 children with valproate therapy. Scheffner D, König S, Rauterberg-Ruland I, Kochen W, Hofmann WJ, Unkelbach S. Epilepsia; 1988 Dec; 29(5):530-42. PubMed ID: 3137017 [Abstract] [Full Text] [Related]
11. [Valproic acid-induced idiosyncratic liver injury in 4 cases]. Xiong H, Liu CT, Zhang YH, Bao XH, Jiang YW, Zhao H, Wu XP, Qin J. Zhonghua Er Ke Za Zhi; 2012 Dec; 50(12):890-4. PubMed ID: 23324142 [Abstract] [Full Text] [Related]
12. Variants p.Q1236H and p.E1143G in mitochondrial DNA polymerase gamma POLG1 are not associated with increased risk for valproate-induced hepatotoxicity or pancreatic toxicity: A retrospective cohort study of patients with epilepsy. Hynynen J, Pokka T, Komulainen-Ebrahim J, Myllynen P, Kärppä M, Pylvänen L, Kälviäinen R, Sokka A, Jyrkilä A, Lähdetie J, Haataja L, Mäkitalo A, Ylikotila P, Eriksson K, Haapala P, Ansakorpi H, Hinttala R, Vieira P, Majamaa K, Rantala H, Uusimaa J. Epilepsia; 2018 Nov; 59(11):2125-2136. PubMed ID: 30255931 [Abstract] [Full Text] [Related]
13. Valproate metabolites and hepatotoxicity in an epileptic population. Tennison MB, Miles MV, Pollack GM, Thorn MD, Dupuis RE. Epilepsia; 1988 Nov; 29(5):543-7. PubMed ID: 3137018 [Abstract] [Full Text] [Related]
14. Valproic acid hepatic fatalities. II. US experience since 1984. Dreifuss FE, Langer DH, Moline KA, Maxwell JE. Neurology; 1989 Feb; 39(2 Pt 1):201-7. PubMed ID: 2492646 [Abstract] [Full Text] [Related]
15. Potential relationships between transaminase abnormality and valproic acid clearance or serum carnitine concentrations in Japanese epileptic patients. Goto S, Seo T, Hagiwara T, Ueda K, Yamauchi T, Nagata S, Ando Y, Ishitsu T, Nakagawa K. J Pharm Pharmacol; 2008 Feb; 60(2):267-72. PubMed ID: 18237476 [Abstract] [Full Text] [Related]
16. Valproic Acid and the Liver Injury in Patients with Epilepsy: An Update. Guo HL, Jing X, Sun JY, Hu YH, Xu ZJ, Ni MM, Chen F, Lu XP, Qiu JC, Wang T. Curr Pharm Des; 2019 Feb; 25(3):343-351. PubMed ID: 30931853 [Abstract] [Full Text] [Related]
17. Fatal liver failure associated with valproate therapy in a patient with Friedreich's disease: review of valproate hepatotoxicity in adults. König SA, Schenk M, Sick C, Holm E, Heubner C, Weiss A, König I, Hehlmann R. Epilepsia; 1999 Jul; 40(7):1036-40. PubMed ID: 10403231 [Abstract] [Full Text] [Related]
18. [Fatal hepatic necrosis during treatment with sodium valproate]. Miguil M, Chlihi A, Mjahed K, Sarf I, Moutawakkil S, Benaguida M. Cah Anesthesiol; 1995 Jul; 43(3):325-6. PubMed ID: 7583902 [Abstract] [Full Text] [Related]
19. [Acute fatal liver insufficiency due to valproic acid therapy]. Binek J, Hany A, Egloff B, Heer M. Schweiz Med Wochenschr; 1991 Feb 16; 121(7):228-33. PubMed ID: 2008603 [Abstract] [Full Text] [Related]
20. Simultaneous toxicities in a child on multiple anticonvulsants. Delima SI, Walsh LE, Golomb MR. J Child Neurol; 2008 Sep 16; 23(9):1054-7. PubMed ID: 18344455 [Abstract] [Full Text] [Related] Page: [Next] [New Search]